Logo

American Heart Association

  2
  0


Final ID: Mo4107

Cardiopulmonary long-term effects 6, 18 and 30 months after severe covid-19 infection

Abstract Body (Do not enter title and authors here): Background: SARS-CoV-2 infection affects the cardiopulmonary system in both the acute and long-term phase. This study aimed to comprehensively assess symptoms and potential long-term impairments 6, 18 and 30 months in patients previously hospitalized for severe Covid-19 infection.
Methods: This prospective registry included patients hospitalized for PCR-confirmed Covid-19 infection. Approximately 6 months post-discharge, follow-up examination included patient history, clinical examination, echocardiography, electrocardiogram, cardiac magnetic resonance imaging (cMRI), chest computed tomography (CT) scan, pulmonary function test (PFT), six-minute walk test (6MWT) and a comprehensive laboratory panel. Patients with pathologic findings during the first visit underwent a second (at 18 months) and third (at 30 months) follow-up examination. Those without pathologic findings or who refused further medical examinations were contacted via phone to inquire about symptoms.
Results: Between July 2020 and April 2022, 200 patients (91% general ward, 9% intensive care unit) were recruited. Due to dropouts, the second visit was conducted in 170 patients, and the third visit in 139 (74 in person, 65 via telephone). Long Covid criteria were fulfilled by 73% at 6 months, 52% at 18 months and 49% at 30 months post-discharge, with fatigue being the most common symptom (Figure 1). Echocardiography at 6 months showed impaired left ventricular function in 15 patients, with normalization in 80% at 18 months and further 66% at 30 months (Figure 2). cMRI revealed pericardial effusions in 28 patients at 6 months, which resolved in 47% at 18 months and in further 60% at 30 months. Signs of peri- or myocarditis were present in 7 patients at 6 months and were resolved in all 4 patients who attended control studies at 18 months. Chest CT scans at 6 months identified post-infectious residues in 41 patients, with full recovery in 20% at 18 months without further normalization after 30 months.
The length of in-hospital stay was identified as a significant predictor for persisting Long Covid 6 months after discharge (95% CI: 1.005 - 1.12, p=0.03).
Conclusion: While the prevalence of Long Covid decreased over time, a significant symptom burden persisted at 6, 18 and even 30 months after severe Covid-19 infection. Structural and functional abnormalities were less frequent compared to reported symptoms, posing a challenge in substantiating the causes of these symptoms.
  • Niebauer, Julia  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Zoufaly, Alexander  ( Clinic Favoriten, Department of Infectious Diseases , Vienna , Austria )
  • Valenta, Rosmarie  ( Clinic Favoriten, Department of Radiology , Vienna , Austria )
  • Charwat-resl, Silvia  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Krestan, Christian  ( Clinic Favoriten, Department of Radiology , Vienna , Austria )
  • Hitzl, Wolfgang  ( Paracelsus Private Medical University, Research and Innovation Management (RIM), Team Biostatistics and Publication of Clinical Trial Study , Salzburg , Austria )
  • Wenisch, Christoph  ( Clinic Favoriten, Department of Infectious Diseases , Vienna , Austria )
  • Bonderman, Diana  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Iscel, Ahmet  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Schedl, Sarah  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Capelle, Christophe  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Kahr, Michael  ( Clinic Floridsdorf , Vienna , Austria )
  • Schamilow, Simon  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Faltas, John  ( Clinic Favoriten, Department of Cardiology and Emergency Medicine , Vienna , Austria )
  • Srdits, Marc  ( Clinic Floridsdorf , Vienna , Austria )
  • Lichtenauer, Michael  ( Paracelsus Medical University of Salzburg, Department of Internal Medicine II, Division of Cardiology, , Salzburg , Austria )
  • Author Disclosures:
    Julia Niebauer: DO NOT have relevant financial relationships | Alexander Zoufaly: No Answer | Rosmarie Valenta: DO NOT have relevant financial relationships | Silvia Charwat-Resl: No Answer | Christian Krestan: No Answer | Wolfgang Hitzl: No Answer | Christoph Wenisch: No Answer | Diana Bonderman: No Answer | Ahmet Iscel: No Answer | Sarah Schedl: No Answer | Christophe Capelle: DO NOT have relevant financial relationships | Michael Kahr: No Answer | Simon Schamilow: No Answer | John Faltas: No Answer | Marc Srdits: DO have relevant financial relationships ; Researcher:Astra Zeneca:Active (exists now) | Michael Lichtenauer: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Imaging in Tissue and Vascular Characterization to Help Answer Clinical Questions

Monday, 11/18/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A Heart Transplant Patient’s Mysterious Illness: A Diagnostic Odyssey

Alkalbani Mutaz, Nayer Hassan, Cochrane Adam, Saeed Ibrahim, Psotka Mitchell, Rollins Allman, Kennedy Jamie, Blumer Vanessa

A Case Series of Papillary Fibroelastomas on the Coumadin ridge

Aboukhatwa Omar, Akiki Elias, Kurmann Reto, Larson Kathryn, Keeney Michael, Bois Melanie, Klarich Kyle

You have to be authorized to contact abstract author. Please, Login
Not Available